These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
211 related items for PubMed ID: 38942156
21. Ceftriaxone ameliorates hippocampal synapse loss by inhibiting microglial/macrophages activation in glial glutamate transporter-1 dependent manner in the APP/PS1 mouse model of Alzheimer's disease. Liu LZ, Fan SJ, Gao JX, Li WB, Xian XH. Brain Res Bull; 2023 Aug; 200():110683. PubMed ID: 37301482 [Abstract] [Full Text] [Related]
22. Echinacoside Improves Cognitive Impairment by Inhibiting Aβ Deposition Through the PI3K/AKT/Nrf2/PPARγ Signaling Pathways in APP/PS1 Mice. Qiu H, Liu X. Mol Neurobiol; 2022 Aug; 59(8):4987-4999. PubMed ID: 35665898 [Abstract] [Full Text] [Related]
23. DL0410 can reverse cognitive impairment, synaptic loss and reduce plaque load in APP/PS1 transgenic mice. Yang RY, Zhao G, Wang DM, Pang XC, Wang SB, Fang JS, Li C, Liu AL, Wu S, Du GH. Pharmacol Biochem Behav; 2015 Dec; 139(Pt A):15-26. PubMed ID: 26476132 [Abstract] [Full Text] [Related]
24. GEPT extract reduces Abeta deposition by regulating the balance between production and degradation of Abeta in APPV717I transgenic mice. Tian J, Shi J, Zhang L, Yin J, Hu Q, Xu Y, Sheng S, Wang P, Ren Y, Wang R, Wang Y. Curr Alzheimer Res; 2009 Apr; 6(2):118-31. PubMed ID: 19355846 [Abstract] [Full Text] [Related]
25. Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer's disease. Kanninen K, Heikkinen R, Malm T, Rolova T, Kuhmonen S, Leinonen H, Ylä-Herttuala S, Tanila H, Levonen AL, Koistinaho M, Koistinaho J. Proc Natl Acad Sci U S A; 2009 Sep 22; 106(38):16505-10. PubMed ID: 19805328 [Abstract] [Full Text] [Related]
26. Huatuo Zaizao pill ameliorates cognitive impairment of APP/PS1 transgenic mice by improving synaptic plasticity and reducing Aβ deposition. Zhang JH, Yu LJ, Yang H, Hui Z, Jiang S, Chen L, Zhao Y, Wang SL, Liu Y, Xu Y. BMC Complement Altern Med; 2018 May 29; 18(1):167. PubMed ID: 29843688 [Abstract] [Full Text] [Related]
27. Protective effect of potassium 2-(l-hydroxypentyl)-benzoate on hippocampal neurons, synapses and dystrophic axons in APP/PS1 mice. Huang L, Zhang Y, Peng Y, Zhao Z, Zhou Y, Wang X, Peng Y. Psychopharmacology (Berl); 2019 Sep 29; 236(9):2761-2771. PubMed ID: 31165206 [Abstract] [Full Text] [Related]
28. Combination of RNA-seq and proteomics reveals the mechanism of DL0410 treatment in APP/PS1 transgenic mouse model of Alzheimer's disease. Zhang B, Zhao J, Yan C, Bai Y, Guo P, Wang C, Wang Z, Du G, Liu A. Biomed Pharmacother; 2024 Aug 29; 177():116940. PubMed ID: 38925020 [Abstract] [Full Text] [Related]
29. Cattle Encephalon Glycoside and Ignotin Ameliorate Palmitoylation of PSD-95 and Enhance Expression of Synaptic Proteins in the Frontal Cortex of a APPswe/PS1dE9 Mouse Model of Alzheimer's Disease. Zhang Y, Hu Y, Han Z, Geng Y, Xia Z, Zhou Y, Wang Z, Wang Y, Kong E, Wang X, Jia J, Zhang H. J Alzheimers Dis; 2022 Aug 29; 88(1):141-154. PubMed ID: 35570485 [Abstract] [Full Text] [Related]
30. Albiflorin ameliorates memory deficits in APP/PS1 transgenic mice via ameliorating mitochondrial dysfunction. Xu YJ, Mei Y, Shi XQ, Zhang YF, Wang XY, Guan L, Wang Q, Pan HF. Brain Res; 2019 Sep 15; 1719():113-123. PubMed ID: 31150651 [Abstract] [Full Text] [Related]
31. SuanZaoRen decoction alleviates neuronal loss, synaptic damage and ferroptosis of AD via activating DJ-1/Nrf2 signaling pathway. Long Q, Li T, Zhu Q, He L, Zhao B. J Ethnopharmacol; 2024 Apr 06; 323():117679. PubMed ID: 38160863 [Abstract] [Full Text] [Related]
32. Puerarin alleviates cognitive impairment and oxidative stress in APP/PS1 transgenic mice. Zhou Y, Xie N, Li L, Zou Y, Zhang X, Dong M. Int J Neuropsychopharmacol; 2014 Apr 06; 17(4):635-44. PubMed ID: 24345484 [Abstract] [Full Text] [Related]
33. Astragalus polysaccharide alleviates cognitive impairment and β-amyloid accumulation in APP/PS1 mice via Nrf2 pathway. Qin X, Hua J, Lin SJ, Zheng HT, Wang JJ, Li W, Ke JJ, Cai HB. Biochem Biophys Res Commun; 2020 Oct 20; 531(3):431-437. PubMed ID: 32800555 [Abstract] [Full Text] [Related]
34. Extract of Danggui-Shaoyao-San ameliorates cognition deficits by regulating DHA metabolism in APP/PS1 mice. Huang J, Wang X, Xie L, Wu M, Zhao W, Zhang Y, Wang Q, Yao L, Li W. J Ethnopharmacol; 2020 May 10; 253():112673. PubMed ID: 32084555 [Abstract] [Full Text] [Related]
35. Neuroprotective effect of emodin against Alzheimer's disease via Nrf2 signaling in U251 cells and APP/PS1 mice. Li Z, Bi H, Jiang H, Song J, Meng Q, Zhang Y, Fei X. Mol Med Rep; 2021 Feb 10; 23(2):. PubMed ID: 33300068 [Abstract] [Full Text] [Related]
36. β-asarone improves learning and memory and reduces Acetyl Cholinesterase and Beta-amyloid 42 levels in APP/PS1 transgenic mice by regulating Beclin-1-dependent autophagy. Deng M, Huang L, Ning B, Wang N, Zhang Q, Zhu C, Fang Y. Brain Res; 2016 Dec 01; 1652():188-194. PubMed ID: 27737765 [Abstract] [Full Text] [Related]
37. Catalpol Ameliorates Neurotoxicity in N2a/APP695swe Cells and APP/PS1 Transgenic Mice. Du J, Liu J, Huang X, Li Y, Song D, Li Q, Lin J, Li B, Li L. Neurotox Res; 2022 Aug 01; 40(4):961-972. PubMed ID: 35699892 [Abstract] [Full Text] [Related]
38. Evaluation of Neuropathological Effects of a High-Fat Diet in a Presymptomatic Alzheimer's Disease Stage in APP/PS1 Mice. Ettcheto M, Petrov D, Pedrós I, Alva N, Carbonell T, Beas-Zarate C, Pallas M, Auladell C, Folch J, Camins A. J Alzheimers Dis; 2016 Jul 14; 54(1):233-51. PubMed ID: 27567882 [Abstract] [Full Text] [Related]
39. (-)-Epigallocatechin-3-gallate alleviates spatial memory impairment in APP/PS1 mice by restoring IRS-1 signaling defects in the hippocampus. Jia N, Han K, Kong JJ, Zhang XM, Sha S, Ren GR, Cao YP. Mol Cell Biochem; 2013 Aug 14; 380(1-2):211-8. PubMed ID: 23660953 [Abstract] [Full Text] [Related]
40. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease. Gu XH, Xu LJ, Liu ZQ, Wei B, Yang YJ, Xu GG, Yin XP, Wang W. Behav Brain Res; 2016 Sep 15; 311():309-321. PubMed ID: 27233830 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]